Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children
Tuesday, October 18, 2011 - 13:01
in Health & Medicine
First results from a large-scale Phase III trial of RTS,S*, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile. The results were announced today at the Malaria Forum hosted by the Bill & Melinda Gates Foundation in Seattle, Washington.